| scholarly article | Q13442814 |
| P2093 | author name string | Xiao-Feng Zhang | |
| Cheng-Jun Sui | |||
| Jia-Mei Yang | |||
| Yan-Ming Zhou | |||
| Lu-Peng Wu | |||
| P2860 | cites work | Risk factors for pancreatic cancer: case-control study | Q34582332 |
| Combined hepatocellular-cholangiocarcinoma had poor outcomes after hepatectomy regardless of Allen and Lisa class or the predominance of intrahepatic cholangiocarcinoma cells within the tumor | Q82662202 | ||
| Clinicopathological analysis of 14 patients with combined hepatocellular carcinoma and cholangiocarcinoma | Q82832754 | ||
| The diagnostic conundrum and liver transplantation outcome for combined hepatocellular-cholangiocarcinoma | Q84113297 | ||
| Clinicopathological characteristics in combined hepatocellular-cholangiocarcinoma: a single center study in Korea | Q35176302 | ||
| Dramatic reduction of liver cancer incidence in young adults: 28 year follow-up of etiological interventions in an endemic area of China | Q37065327 | ||
| A case of combined hepatocellular-cholangiocarcinoma with underlying schistosomiasis | Q37205355 | ||
| Viral hepatitis-associated intrahepatic cholangiocarcinoma shares common disease processes with hepatocellular carcinoma | Q37225736 | ||
| Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma | Q37246194 | ||
| Diabetes mellitus: a "true" independent risk factor for hepatocellular carcinoma? | Q37613284 | ||
| Nonresectable combined hepatocellular carcinoma and cholangiocarcinoma: analysis of the response and prognostic factors after transcatheter arterial chemoembolization | Q37716366 | ||
| Pathology of combined hepatocellular‐cholangiocarcinoma | Q37783344 | ||
| Surgical treatments and prognoses of patients with combined hepatocellular carcinoma and cholangiocarcinoma | Q38497061 | ||
| Parallel induction of cell proliferation and inhibition of cell differentiation in hepatic progenitor cells by hepatitis B virus X gene | Q39314343 | ||
| Comparison of clinical characteristics of combined hepatocellular-cholangiocarcinoma and other primary liver cancers. | Q42984807 | ||
| Prevalence of diabetes mellitus in Japanese patients infected chronically with hepatitis C virus | Q43048623 | ||
| Clinical and pathological analysis of 27 patients with combined hepatocellular-cholangiocarcinoma in an Asian center | Q43656939 | ||
| A clinicopathological study on combined hepatocellular and cholangiocarcinoma | Q43657340 | ||
| Clinicopathologic analysis of combined hepatocellular-cholangiocarcinoma according to the latest WHO classification | Q43678782 | ||
| Prognostic impact of cholangiocellular and sarcomatous components in combined hepatocellular and cholangiocarcinoma | Q45096246 | ||
| Intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma: a Western experience. | Q45279934 | ||
| The role of diabetes in hepatocellular carcinoma: a case-control study among United States Veterans | Q45334263 | ||
| Long-term effect of lamivudine treatment on the incidence of hepatocellular carcinoma in patients with hepatitis B virus infection | Q45360538 | ||
| Hepatitis B virus infection and intrahepatic cholangiocarcinoma in Korea: a case-control study | Q45394401 | ||
| Clinicopathological factors impact the survival outcome following the resection of combined hepatocellular carcinoma and cholangiocarcinoma. | Q51300505 | ||
| Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis. | Q53272324 | ||
| Combined hepatocellular cholangiocarcinoma originating from hepatic progenitor cells: immunohistochemical and double-fluorescence immunostaining evidence. | Q53325259 | ||
| A histopathological study on combined hepatocellular and cholangiocarcinoma: cholangiocarcinoma component is originated from hepatocellular carcinoma. | Q53333044 | ||
| Clinical and molecular analysis of combined hepatocellular-cholangiocarcinomas. | Q53366237 | ||
| Hepatic 'stem cell' malignancies in adults: four cases. | Q53376535 | ||
| Flow cytometric isolation and clonal identification of self-renewing bipotent hepatic progenitor cells in adult mouse liver. | Q53449416 | ||
| An immunohistochemical analysis of 13 cases with combined hepatocellular and cholangiocellular carcinoma. | Q53466518 | ||
| Combined hepatocellular and cholangiocarcinoma: CT findings with emphasis on multiphasic helical CT. | Q53473495 | ||
| Recurrence patterns of combined hepatocellular-cholangiocarcinoma on enhanced computed tomography. | Q53501947 | ||
| Clinicopathologic features and prognosis of combined hepatocellular cholangiocarcinoma. | Q53626745 | ||
| Long-term prognosis of combined hepatocellular and cholangiocarcinoma after curative resection comparison with hepatocellular carcinoma and cholangiocarcinoma | Q57226919 | ||
| Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B | Q58235862 | ||
| Combined hepatocellular and cholangiocarcinoma: proposed criteria according to cytokeratin expression and analysis of clinicopathologic features | Q71710116 | ||
| Combined hepatocellular carcinoma and cholangiocarcinoma: Clinical features and computed tomographic findings | Q72102297 | ||
| Combined hepatocellular and cholangiocarcinoma: a clinicopathologic study of 26 resected cases | Q73797012 | ||
| Combined hepatocellular-cholangiocarcinoma: a clinicopathological study | Q77299013 | ||
| Expression of sialyl-Tn, Tn and T antigens in primary liver cancer | Q77872186 | ||
| Combined hepatocellular and cholangiocarcinoma: demographic, clinical, and prognostic factors | Q77879718 | ||
| Combined hepatocellular and cholangiocarcinoma: clinical features and prognostic study in a Thai population | Q79397825 | ||
| Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study | Q79835026 | ||
| Clinicopathological characteristics of 15 patients with combined hepatocellular carcinoma and cholangiocarcinoma | Q79996094 | ||
| Comparison of combined hepatocellular and cholangiocarcinoma with hepatocellular carcinoma and intrahepatic cholangiocarcinoma | Q80337206 | ||
| A clinical study of 11 cases of combined hepatocellular-cholangiocarcinoma Assessment of enhancement patterns on dynamics computed tomography before resection | Q81889016 | ||
| P433 | issue | 35 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cholangiocarcinoma | Q124292 |
| P304 | page(s) | 12615-12620 | |
| P577 | publication date | 2014-09-01 | |
| P1433 | published in | World Journal of Gastroenterology | Q15708885 |
| P1476 | title | Risk factors for combined hepatocellular-cholangiocarcinoma: a hospital-based case-control study | |
| P478 | volume | 20 |
| Q30370015 | Addition and Subtraction Theory of TCM Using Xiao-Chaihu-Decoction and Naturopathy in Predicting Survival Outcomes of Primary Liver Cancer Patients: A Prospective Cohort Study |
| Q64069091 | Association between periductal fibrosis and bile duct dilatation among a population at high risk of cholangiocarcinoma: a cross-sectional study of cholangiocarcinoma screening in Northeast Thailand |
| Q40621862 | Biphenotypic Primary Liver Carcinomas: Assessing Outcomes of Hepatic Directed Therapy. |
| Q37675494 | Clinical features, histology, and histogenesis of combined hepatocellular-cholangiocarcinoma. |
| Q26749446 | Combined hepatocellular cholangiocarcinoma: Controversies to be addressed |
| Q90372062 | Combined hepatocellular-cholangiocarcinoma: An analysis of clinicopathological characteristics after surgery |
| Q42132430 | Composite liver tumors: a radiologic-pathologic correlation |
| Q30240015 | HBV Infection Status and the Risk of Cholangiocarcinoma in Asia: A Meta-Analysis |
| Q36276041 | Influence of cirrhosis on long-term prognosis after surgery in patients with combined hepatocellular-cholangiocarcinoma |
| Q58773535 | Negative impact of hepatitis B surface seroclearance on prognosis of hepatitis B-related primary liver cancer |
| Q54247807 | Surgical Treatment of Combined Hepatocellular-Cholangiocarcinoma is as Effective in Elderly Patients as it is in Younger Patients: A Propensity Score Matching Analysis. |
| Q93337433 | Viral hepatitis B and C infections increase the risks of intrahepatic and extrahepatic cholangiocarcinoma: Evidence from a systematic review and meta-analysis |
Search more.